MoneyWorks4Me

Concord Drugs informs about compliance certificate

14 Oct 2025 Evaluate

Concord Drugs has informed that it enclosed the Certificate from Registrar and Share Transfer Agent (R&T Agent) - Aarthi Consultants under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Concord Drugs for the quarter ended 30th September, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1740.20
Dr. Reddys Labs. 1226.40
Cipla 1318.80
Lupin 1907.45
Zydus Lifesciences 1124.90
View more..